Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo.
The similarity in risk factors for insulin resistance and colorectal cancer (CRC) led to the hypothesis that markers of insulin resistance, such as elevated circulating levels of insulin, glucose, fatty acids, and triglycerides, are energy sources and growth factors in the development of CRC. The objective was thus to examine the individual and combined effects of these circulating factors on colorectal epithelial proliferation in vivo. Rats were fasted overnight, randomized to six groups, infused iv with insulin, glucose, and/or Intralipid for 10 h, and assessed for 5-bromo-2-deoxyuridine labeling of replicating DNA in colorectal epithelial cells. Intravenous infusion of insulin, during a 10-h euglycemic clamp, increased colorectal epithelial proliferation in a dose-dependent manner. The addition of hyperglycemia to hyperinsulinemia did not further increase proliferation. Intralipid infusion alone did not affect proliferation; however, the combination of insulin, glucose, and Intralipid infusion resulted in greater hyperinsulinemia than the infusion of insulin alone and further increased proliferation. Insulin infusion during a 10-h euglycemic clamp decreased total IGF-I levels and did not affect insulin sensitivity. These results provide evidence for an acute role of insulin, at levels observed in insulin resistance, in the proliferation of colorectal epithelial cells in vivo.
Tran
Thien T
TT
Departments of Nutritional Sciences, University of Toronto, Canada.
Naigamwalla
Dinaz
D
Oprescu
Andrei I
AI
Lam
Loretta
L
McKeown-Eyssen
Gail
G
Bruce
W Robert
WR
Giacca
Adria
A
D000818:Animals; D001835:Body Weight; D049109:Cell Proliferation; D003106:Colon / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000209:etiology*; D005217:Fat Emulsions, Intravenous / Q000494:pharmacology; D006946:Hyperinsulinism / Q000150:complications / Q000473:pathology*; D007333:Insulin Resistance; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D012007:Rectum / Q000473:pathology*; D012044:Regression Analysis
D005217:Fat Emulsions, Intravenous; D007334:Insulin-Like Growth Factor I